Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
Use this IMCR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IMCR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IMCR SEC filings page. Lician reads the product cache first so this HTML stays unique to Immunocore Holdings Ltd even when a live quote feed is slow.
Latest cached year on this hub. Full IMCR income, balance, and cash tables.